In conclusion, this study provides a framework for understanding the protective potential of CAV1 against hepatic steatosis and hepatocyte injury in NAFLD, which is probably due to its functions in modulating the expression of lipid metabolism genes. This evidence concerns the gene CAV1 and metabolic dysfunction-associated steatotic liver disease.